Company Rating : SINOPHARM
 All 
 News subscription  |  Index watch  |  All in 1 chart  |  Rating  |  Performance  |  Financial journal  |  Major data announcement 
 
Name Updated Value Open High Low Change
SINOPHARM 2024-05-08 10:22 20.85 20.55 20.95 20.35 20.85
DateBroker NameCompany nameRatingTarget PriceOther Info
 
03-13 Daiwa  SINOPHARM →Buy25→25  Data   Hist. 
03-11 Nomura  SINOPHARM →Buy33.31↓32.39  Data   Hist. 
12-21 Morgan Stanley  SINOPHARM ↓Overweight30↓29  Data   Hist. 
11-07 First Shanghai  SINOPHARM →Buy27.45→27.45  Data   Hist. 
11-02 China Intl Capital  SINOPHARM 26→26  Data   Hist. 
11-01 UOB  SINOPHARM 30↓25  Data   Hist. 
10-24 Nomura  SINOPHARM 36.28↓33.31  Data   Hist. 
09-06 UBS  SINOPHARM ↓Buy28↓26  Data   Hist. 
08-30 CLSA  SINOPHARM ↓Buy23.51↓22.85  Data   Hist. 
08-30 Goldman Sachs  SINOPHARM ↓Neutral22.38↓21.25  Data   Hist. 
05-27 HSBC  SINOPHARM 29↓25  Data   Hist. 
04-25 CLSA  SINOPHARM ↓Buy23.7↓23.51  Data   Hist. 
03-22 Morgan Stanley  SINOPHARM ↑Mkt Perform20.6↑22.3  Data   Hist. 
03-22 Citibank  SINOPHARM ↓Buy28↓26  Data   Hist. 
01-28 Morgan Stanley  SINOPHARM ↓Mkt Perform21↓20.6  Data   Hist. 
11-30 Morgan Stanley  SINOPHARM ↓Mkt Perform30↓21  Data   Hist. 
11-01 CLSA  SINOPHARM ↓Buy28.18↓25.9  Data   Hist. 
10-26 Credit Suisse  SINOPHARM ↓Outperform26↓25  Data   Hist. 
08-24 Credit Suisse  SINOPHARM ↓Outperform29↓26  Data   Hist. 
07-27 Morgan Stanley  SINOPHARM 34↓30.6  Data   Hist. 
 
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.